Literature DB >> 12803886

Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4).

Thierry Roger1, Céline Froidevaux, Christian Martin, Thierry Calandra.   

Abstract

The cytokine macrophage migration inhibitory factor (MIF) has emerged recently as an important mediator of inflammation and innate immunity. MIF is rapidly released by macrophages after stimulation with microbial products and pro-inflammatory cytokines and, in turn, stimulates the production of pro-inflammatory mediators by immune cells. Immunoneutralization of MIF or deletion of the Mif gene was shown to protect animals from lethal endotoxemia, staphylococcal toxic shock and septic shock in experimental models of bacterial peritonitis. To investigate the function of MIF in innate immunity, we studied the response of macrophages expressing reduced levels of MIF to microbial products. These cells were generated by transduction of an antisense MIF adenovirus or by stable transfection with an antisense MIF plasmid or were obtained from MIF-knockout mice. MIF-deficient macrophages were shown to be hyporesponsive to stimulation with LPS and Gram-negative bacteria. The defect was associated with a down-regulation of Toll-like receptor 4 (TLR4), the signal transducing molecule of the LPS receptor complex. Immunoneutralization of extracellular MIF decreased TLR4 expression and responses of macrophages to LPS, indicating that MIF may exert autocrine effects. These findings identify an important role for MIF in innate immunity and provide a rationale for the development of anti-MIF strategy for the treatment of patients with Gram-negative septic shock.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12803886     DOI: 10.1179/096805103125001513

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  42 in total

1.  Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor.

Authors:  Athar Alam; Saikat Haldar; Hirekodathakallu V Thulasiram; Rahul Kumar; Manish Goyal; Mohd Shameel Iqbal; Chinmay Pal; Sumanta Dey; Samik Bindu; Souvik Sarkar; Uttam Pal; Nakul C Maiti; Uday Bandyopadhyay
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

Review 2.  TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme-Future Perspectives.

Authors:  Jakub Litak; Cezary Grochowski; Joanna Litak; Ida Osuchowska; Krzysztof Gosik; Elżbieta Radzikowska; Piotr Kamieniak; Jacek Rolinski
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

3.  Novel half-life extended anti-MIF nanobodies protect against endotoxic shock.

Authors:  Amanda Sparkes; Patrick De Baetselier; Lea Brys; Inês Cabrito; Yann G-J Sterckx; Steve Schoonooghe; Serge Muyldermans; Geert Raes; Richard Bucala; Peter Vanlandschoot; Jo A Van Ginderachter; Benoît Stijlemans
Journal:  FASEB J       Date:  2018-01-25       Impact factor: 5.191

4.  Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice.

Authors:  Zhigang Wang; Meng Wei; Meng Wang; Lei Chen; Hua Liu; Yi Ren; Kehui Shi; Hongli Jiang
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

5.  MIF/CD74 axis participates in inflammatory activation of Schwann cells following sciatic nerve injury.

Authors:  Honghua Song; Ziwen Zhu; Yue Zhou; Nan Du; Tiancheng Song; Hao Liang; Xiaojun Chen; Yingjie Wang; Yongjun Wang; Yuming Hu
Journal:  J Mol Histol       Date:  2019-06-13       Impact factor: 2.611

6.  Ostertagia ostertagi macrophage migration inhibitory factor is present in all developmental stages and may cross-regulate host functions through interaction with the host receptor.

Authors:  Guanggang Qu; Raymond Fetterer; Lin Leng; Xin Du; Dante Zarlenga; Zhiqiang Shen; Wenyu Han; Richard Bucala; Wenbin Tuo
Journal:  Int J Parasitol       Date:  2014-02-28       Impact factor: 3.981

7.  Increased TLR4 expression and downstream cytokine production in immunosuppressed adults compared to non-immunosuppressed adults.

Authors:  Dana W Dunne; Albert Shaw; Linda K Bockenstedt; Heather G Allore; Shu Chen; Stephen E Malawista; Lin Leng; Yuka Mizue; Marta Piecychna; Lin Zhang; Virginia Towle; Richard Bucala; Ruth R Montgomery; Erol Fikrig
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

8.  Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.

Authors:  Chia-Chang Chuang; Yin-Ching Chuang; Wen-Teng Chang; Chi-Chung Chen; Lien-I Hor; A-Ming Huang; Pui-Ching Choi; Chi-Yun Wang; Po-Chin Tseng; Chiou-Feng Lin
Journal:  BMC Immunol       Date:  2010-10-12       Impact factor: 3.615

9.  Differential and cell-type specific regulation of responses to Toll-like receptor agonists by ISO-1.

Authors:  Peter W West; Lisa C Parker; Jon R Ward; Ian Sabroe
Journal:  Immunology       Date:  2008-03-18       Impact factor: 7.397

10.  Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis.

Authors:  W Joost Wiersinga; Thierry Calandra; Liesbeth M Kager; Gerritje J W van der Windt; Thierry Roger; Didier le Roy; Sandrine Florquin; Sharon J Peacock; Fred C G J Sweep; Tom van der Poll
Journal:  PLoS Negl Trop Dis       Date:  2010-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.